Laboratorios Sophia S.a De C.v.

This study tested a new eye medication called PRO-169 against a standard treatment (ranibizumab) for diabetic macular edema, a condition that causes vision loss in people with diabetes. 510 adults with diabetes received injections into the eye over one year. The goal was to see i…

This study tested three different eye drops (Humylub Ofteno, Hyabak, and Lagricel Ofteno) in 182 adults with mild to moderate dry eye. Participants used the drops four times a day for 30 days. The main goal was to see if Humylub Ofteno worked as well as the other two in reducing …

This study compared two different eye drops (Lagricel and Thealoz Duo) to see which helps the eye's outer layer heal faster after a type of laser eye surgery called PRK. A total of 96 people who had just had PRK surgery took part. The main goal was to measure how quickly the corn…

This early-phase study tested the safety of PRO-201 eye drops (a low-dose atropine solution) in 29 healthy adults aged 18 to 35. The main goal was to see if the drops cause unexpected side effects or light sensitivity. Researchers also checked vision, eye pressure, and comfort. T…

This study tested a new gel-like substance called PRO-149 used during cataract surgery to protect the eye. 36 adults with age-related cataracts received either the new gel or a standard gel during their operation. The main goal was to check safety by measuring changes in eye cell…

This study tested three different schedules of Lagricel Ofteno eye drops (a preservative-free lubricant) in 141 adults with mild to moderate dry eye. Participants used the drops either twice, four times, or six times daily for several weeks. The main goal was to see which schedul…

This study tested whether Manzanilla Sophia eye drops work as well as Meticel Ofteno eye drops for relieving eye fatigue and discomfort. 167 adults with eye irritation from medications or other causes participated. The main goal was to see if both drops provide similar relief bas…

This early-stage study tested a new eye gel called PRO-165 in 32 healthy adults to see if it is safe and tolerable compared to an existing gel (Artelac). The goal is to provide relief for dry eye symptoms. Participants used the gel and were monitored for side effects and comfort.

This early-stage study tested whether PRO-232 eye drops are safe and tolerable in 28 healthy adults aged 18 to 45. Participants received either the eye drops or a placebo, and researchers monitored for side effects, eye pressure changes, and stinging. Since this was a Phase 1 saf…